Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details Narrative)

STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)														1 Months Ended	3 Months Ended	6 Months Ended	9 Months Ended		12 Months Ended
STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)	Jun. 11, 2018	May 16, 2018	May 15, 2018	Apr. 24, 2018	Apr. 19, 2018	Apr. 16, 2018	Apr. 02, 2018	Aug. 24, 2017	Jul. 19, 2017	Jul. 14, 2017	Jul. 13, 2017	Dec. 06, 2016	Sep. 22, 2016	Jul. 31, 2017	Jun. 30, 2018	Jun. 30, 2018	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2017	Apr. 04, 2018	Aug. 21, 2017	Apr. 05, 2016	Mar. 26, 2013	Dec. 10, 2012	Mar. 22, 2012	Aug. 03, 2006
Common stock authorized															250,000,000	250,000,000	250,000,000		500,000,000
Common stock outstanding															6,261,597	6,261,597	6,261,597		4,299,311
Number of options outstanding															888,059	888,059	888,059		554,083
Common stock exercise price (in dollars per share)															$ 10.49	$ 10.49	$ 10.49		$ 16.14
Total unrecognized stock-based compensation															$ 1,388,400	$ 1,388,400	$ 1,388,400	$ 641,600
Number of vested shares																	560,929		249,284
Number of unvested shares															327,069	327,069	327,069		304,799
Gross cash proceeds																		2,981,300
Restricted Stock [Member]
Number of equity instruments other than options outstanding															406,564	406,564	406,564		222,750
Total unrecognized stock-based compensation															$ 186,600	$ 186,600	$ 186,600	224,900
Number of vested shares																			167,708
Number of unvested shares															75,483	75,483	75,483		55,042
Number of shares granted under the plan																	183,814
Stock Option [Member]
Total unrecognized stock-based compensation															$ 1,201,800	$ 1,201,800	$ 1,201,800	$ 416,700
2006 Stock Incentive Plan [Member]
Common stock outstanding															1,452	1,452	1,452
Number of shares reserved for future issuance																										3,339
2012 Omnibus Incentive Compensation Plan [Member]
Common stock purchase price (in dollars per share)																					$ 0.001
Common stock authorized																					975,000
Weighted exercise price of awarded shares (in dollars per share)															$ 5.27	$ 5.27	$ 5.27
Number of options outstanding															886,546	886,546	886,546
Common stock exercise price (in dollars per share)	$ 2.35	$ 2.98
Number of options authorized																						200,000	75,000	27,500	1,667
Number of authorized shares available for grant previously																					885,781
Number of authorized shares available for grant																					1,570,248
Maximum number of shares granted to individual																					150,000
Number of stock options granted	5,000	10,000
Description of plan terms													of each year through 2022, automatically increases the number of shares subject to the 2012 Plan by the lesser of: (a) a number equal to 10% of the shares of Common Stock authorized under the 2012 Plan as of the preceding December 31st, or (b) an amount, or no amount, as determined by the Board, but in no event may the number of shares of Common Stock authorized under the 2012 Plan exceed 885,781 and (iii) increase the annual individual award limits under the 2012 Plan to 100,000 shares of Common Stock, subject to adjustment in accordance with the 2012 Plan. Per the above mentioned “evergreen” provision, an additional 50,000 shares were automatically allocated for distribution under the 2012 Plan as of January 1, 2017.
2012 Omnibus Incentive Compensation Plan [Member] \| Restricted Stock [Member]
Number of shares reserved for future issuance															206,890	206,890	206,890
Number of equity instruments other than options outstanding															406,564	406,564	406,564
Warrant [Member] \| Pro-Rate Option [Member]
Number of common stock issued											2,539,061
Warrant exercise price (in dollars per share)											$ 5.25
Number of each warrant called											1
Warrant [Member] \| Public Offering [Member]
Number of common stock issued									134,000					1,675,000
Common Stock [Member] \| Public Offering [Member]
Number of common stock issued														1,675,000
Maximum [Member] \| 2006 Stock Incentive Plan [Member]
Common stock exercise price (in dollars per share)																										$ 3,300
Maximum [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share)															$ 600.00	$ 600.00	$ 600.00
Minimum [Member] \| 2006 Stock Incentive Plan [Member]
Common stock exercise price (in dollars per share)																										$ 2,400
Minimum [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Common stock exercise price (in dollars per share)															1.55	$ 1.55	1.55
Underwriters [Member] \| Warrant [Member] \| 45-day Option Over-Allotment Option [Member]
Number of common stock issued								213,800
Mr. Robin L. Smith, M.D [Member] \| 2012 Plan [Member]
Number of options outstanding						50,000														75,000
Common stock exercise price (in dollars per share)						$ 1.99														$ 1.55
Senior Consultants [Member] \| 2012 Plan [Member]
Number of options outstanding																				213,000
Common stock exercise price (in dollars per share)																				$ 1.55
Second Common Stock Purchase Agreement [Member] \| Aspire Capital Fund, LLC [Member]
Number of common shares purchased			10,000,000
Agreement term			30 months
Common stock purchase price (in dollars per share)	$ 7.25		$ 0.50
Description of purchase notice			Amount equal to 50,000 shares and the closing sale price of the Company's stock is greater than $0.50 per share, the Company also has the right, in its sole discretion, to present Aspire Capital with a volume-weighted average price purchase notice (each, a “VWAP Purchase Notice”) directing Aspire Capital to purchase an amount of stock equal to up to 30% of the aggregate shares of the Company’s common stock traded on its principal market on the next trading day (the “VWAP Purchase Date”), subject to a maximum number of shares the Company may determine. The purchase price per share pursuant to such VWAP Purchase Notice is generally 95% of the volume-weighted average price for the Company’s common stock traded on its principal market on the VWAP Purchase Date.
Number of common stock issued	222,222
Proceeds from issuance of private placement	$ 500,000
Second Common Stock Purchase Agreement [Member] \| Aspire Capital Fund, LLC [Member] \| Commitment Shares [Member]
Number of common shares purchased			2,500,000
Second Common Stock Purchase Agreement [Member] \| Aspire Capital Fund, LLC [Member] \| Maximum [Member]
Number of shares sold per day			50,000
First Common Stock Purchase Agreement [Member] \| Aspire Capital Fund, LLC [Member]
Number of common shares purchased												10,000,000				1,180,000
Agreement term												30 months
Common stock purchase price (in dollars per share)												$ 0.50			$ 2.00	$ 2.00	$ 2.00
Description of purchase notice												Amount equal to 50,000 shares and the closing sale price of the Company's stock is greater than $0.50 per share, the Company also has the right, in its sole discretion, to present Aspire Capital with a volume-weighted average price purchase notice (each, a “VWAP Purchase Notice”) directing Aspire Capital to purchase an amount of stock equal to up to 30% of the aggregate shares of the Company’s common stock traded on its principal market on the next trading day (the “VWAP Purchase Date”), subject to a maximum number of shares the Company may determine. The purchase price per share pursuant to such VWAP Purchase Notice is generally 95% of the volume-weighted average price for the Company’s common stock traded on its principal market on the VWAP Purchase Date.
Gross cash proceeds																$ 2,400,000
First Common Stock Purchase Agreement [Member] \| Aspire Capital Fund, LLC [Member] \| Maximum [Member]
Number of shares sold per day												50,000
Chairman Services Agreement [Member] \| Mr. Robin L. Smith, M.D [Member]
Annual cash fee				$ 250,000											$ 300,000
Chairman Services Agreement [Member] \| Mr. Robin L. Smith, M.D [Member] \| Stock Option [Member]
Expiration period										10 years
Chairman Services Agreement [Member] \| Mr. Robin L. Smith, M.D [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Restricted Stock [Member]
Number of shares granted under the plan										25,000
Chairman Services Agreement [Member] \| Mr. Robin L. Smith, M.D [Member] \| 2012 Omnibus Incentive Compensation Plan [Member] \| Stock Option [Member]
Number of stock options granted										75,000
Number of option to purchase granted annual award limits										50,000
Chairman Services Agreement [Member] \| Mr. Robin L. Smith, M.D [Member] \| 2012 Plan [Member]
Number of stock options granted						50,000
Employment Agreement [Member] \| Mr. George C. Carpenter, IV [Member]
Annual cash fee					$ 206,250										$ 270,000
Employment Agreement [Member] \| Mr. George C. Carpenter, IV [Member] \| 2012 Plan [Member] \| Restricted Stock [Member]
Number of stock options granted					34,380
Advisory Agreement [Member] \| Maxim Group LLC [Member]
Description of compensation under the agreement							The agreement shall be 100,000 shares of the Company’s Common Stock, payable in one payment of 50,000 shares of Common Stock and five payments of 10,000 shares of Common Stock.